181 related articles for article (PubMed ID: 19500931)
1. Analysis of perfusion weighted image of CNS lymphoma.
Lee IH; Kim ST; Kim HJ; Kim KH; Jeon P; Byun HS
Eur J Radiol; 2010 Oct; 76(1):48-51. PubMed ID: 19500931
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging.
Liao W; Liu Y; Wang X; Jiang X; Tang B; Fang J; Chen C; Hu Z
Acta Radiol; 2009 Mar; 50(2):217-25. PubMed ID: 19096950
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.
Hakyemez B; Erdogan C; Bolca N; Yildirim N; Gokalp G; Parlak M
J Magn Reson Imaging; 2006 Oct; 24(4):817-24. PubMed ID: 16958061
[TBL] [Abstract][Full Text] [Related]
4. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
Server A; Kulle B; Maehlen J; Josefsen R; Schellhorn T; Kumar T; Langberg CW; Nakstad PH
Acta Radiol; 2009 Jul; 50(6):682-9. PubMed ID: 19449234
[TBL] [Abstract][Full Text] [Related]
5. Atypical imaging features of primary central nervous system lymphoma that mimics glioblastoma: utility of intravoxel incoherent motion MR imaging.
Suh CH; Kim HS; Lee SS; Kim N; Yoon HM; Choi CG; Kim SJ
Radiology; 2014 Aug; 272(2):504-13. PubMed ID: 24697149
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of CNS tumors: are all contrast agents created the same?
Essig M
Neuroradiology; 2006 Apr; 48 Suppl 1():3-8. PubMed ID: 16699847
[TBL] [Abstract][Full Text] [Related]
7. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors.
Calli C; Kitis O; Yunten N; Yurtseven T; Islekel S; Akalin T
Eur J Radiol; 2006 Jun; 58(3):394-403. PubMed ID: 16527438
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging.
Ding Y; Xing Z; Liu B; Lin X; Cao D
Brain Behav; 2014; 4(6):841-9. PubMed ID: 25365807
[TBL] [Abstract][Full Text] [Related]
10. Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI.
Hakyemez B; Erdogan C; Gokalp G; Dusak A; Parlak M
Clin Radiol; 2010 Jan; 65(1):15-20. PubMed ID: 20103416
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
[TBL] [Abstract][Full Text] [Related]
12. Parenchymal lymphoma of the brain on initial MR imaging: a comparative study between primary and secondary brain lymphoma.
Senocak E; Oguz KK; Ozgen B; Mut M; Ayhan S; Berker M; Ozdemir P; Cila A
Eur J Radiol; 2011 Aug; 79(2):288-94. PubMed ID: 20202775
[TBL] [Abstract][Full Text] [Related]
13. [Characteristic imaging features of primary central nervous system lymphoma in comparison with pathological findings].
Liu HY; Zhang XL; Chen YP; Qiu SJ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Feb; 29(2):333-6. PubMed ID: 19246316
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance dynamic susceptibility-weighted contrast-enhanced perfusion imaging in the diagnosis of posterior fossa hemangioblastomas and pilocytic astrocytomas: initial results.
Kumar VA; Knopp EA; Zagzag D
J Comput Assist Tomogr; 2010; 34(6):825-9. PubMed ID: 21084895
[TBL] [Abstract][Full Text] [Related]
15. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
Küker W; Nägele T; Thiel E; Weller M; Herrlinger U
Neurology; 2005 Oct; 65(7):1129-31. PubMed ID: 16217075
[TBL] [Abstract][Full Text] [Related]
16. Glioblastomas vs. lymphomas: more diagnostic certainty by using susceptibility-weighted imaging (SWI).
Peters S; Knöß N; Wodarg F; Cnyrim C; Jansen O
Rofo; 2012 Aug; 184(8):713-8. PubMed ID: 22618484
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced magnetic resonance imaging of central nervous system tumors: agents, mechanisms, and applications.
Essig M; Weber MA; von Tengg-Kobligk H; Knopp MV; Yuh WT; Giesel FL
Top Magn Reson Imaging; 2006 Apr; 17(2):89-106. PubMed ID: 17198225
[TBL] [Abstract][Full Text] [Related]
18. Characterization of pancreatic metastases from primary lung cancer using magnetic resonance imaging.
Xi-wen S; Shu-zhen C
Clin Imaging; 2010; 34(5):351-4. PubMed ID: 20813298
[TBL] [Abstract][Full Text] [Related]
19. Primary CNS lymphomas prognosis.
Ferreri AJ; Reni M; Zucca E; Cavalli F
J Clin Oncol; 2007 Sep; 25(27):4322-4; author reply 4324-5. PubMed ID: 17878489
[No Abstract] [Full Text] [Related]
20. Imaging features of primary extranodal lymphomas.
Chua SC; Rozalli FI; O'Connor SR
Clin Radiol; 2009 Jun; 64(6):574-88. PubMed ID: 19414080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]